Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab as Adjuvant Therapy for Choroidal Melanoma
NCT00680225Phase 3Completed
- Start
- Sep 2007
- Primary completion
- Jul 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in choroidal melanoma. Started Sep 2007; status: completed.
02
Drugs
ranibizumab
03
Conditions
choroidal melanoma
Beyond the preview
Go deeper on NCT00680225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680225.